AstraZeneca’s experimental blood cancer drug gets US priority review
British-Swedish AstraZeneca’s drug for treatment of a form of blood cancer has been granted a Priority Review in the US by the drug.
Drugs
Health
Pharma
Drugs
Health
Pharma
AstraZeneca’s trial drug for mantle cell lymphoma raises survival rate
AstraZeneca’s mantle cell lymphoma combination rug, Calquence, reduced the risk of disease progression or death by up to 27%, according to a company.
Drugs
Medical
Pharma
Eli Lilly gets FDA nod for blood cancer drug
Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.